Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Markers for hepatocellular carcinoma.

A H Wu1, S Sell

  • 1University of Texas Medical School, Houston.

Immunology Series
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Alpha fetoprotein (AFP) is a key marker for hepatocellular cancer (HCC) detection and monitoring. Early screening in high-risk populations significantly improves survival rates for HCC patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Titration strategy of sacubitril/valsartan in patients with heart failure with reduced ejection fraction and hypotension].

Zhonghua xin xue guan bing za zhi·2023
Same author

[Predictive value of CONUT score and dialysis age for peritoneal dialysis-associated peritonitis].

Zhonghua yi xue za zhi·2023
Same author

[Analysis of factors affecting live birth outcome of frozen-thawed embryo transfer cycle].

Zhonghua yi xue za zhi·2021
Same author

The impacts of coronavirus disease 2019 (COVID-19) preventive and control interventions on other infectious diseases in China.

Infection control and hospital epidemiology·2021
Same author

[Interpretation of group standard for <i>Clostridioides difficile</i> infection diagnosis].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2021
Same author

[2019 novel coronavirus: appropriate rather than undue protection].

Zhonghua nei ke za zhi·2020

Area of Science:

  • Hepatology
  • Oncology
  • Biomarker Discovery

Background:

  • Hepatocellular cancer (HCC) is a prevalent global cancer, particularly in Asia and Africa.
  • Key risk factors include hepatitis B, alcohol consumption, cirrhosis, and aflatoxin exposure.
  • Early detection of HCC remains a challenge, impacting treatment outcomes.

Purpose of the Study:

  • To evaluate the utility of Alpha fetoprotein (AFP) as a biomarker for hepatocellular cancer (HCC).
  • To assess the effectiveness of screening high-risk populations for early HCC detection.
  • To explore novel diagnostic and therapeutic strategies for HCC.

Main Methods:

  • Analysis of AFP levels in serum for HCC diagnosis and monitoring.
  • Comparison of AFP with other potential serum and tissue markers.

Related Experiment Videos

  • Evaluation of screening programs in high-risk populations.
  • Investigating immunodetection and immunotherapy approaches for HCC.

    • Main Results:

    • AFP is a significant marker, but often elevated late in HCC progression.
    • Screening high-risk groups in China led to a dramatic increase in survival rates post-resection.
    • Ultrasonography shows higher sensitivity than immunodetection for HCC.
    • AFP levels effectively monitor treatment response and indicate recurrence.

    Conclusions:

    • AFP is a valuable tool for HCC monitoring, especially for AFP-producing tumors.
    • Early detection through screening significantly improves HCC patient survival.
    • Further research into AFP-conjugated therapies shows promise for HCC treatment.